Navigation Links
Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
Date:7/10/2008

- Commitment Reflects Eisai's human health care (hhc) Mission to Serve the

Needs of Patients and Families -

WOODCLIFF LAKE, N.J., July 10 /PRNewswire/ -- Eisai Inc., as a member company of the Pharmaceutical Research and Manufacturers of America (PhRMA), today announced that it has renewed its commitment to pursue policies and practices that best serve the needs of patients and the healthcare community in accordance with PhRMA's newly revised Code on Interactions with Healthcare Professionals.

The revised PhRMA Code, effective January 2009, builds upon improvements already made since its adoption and is part of an ongoing industry effort to ensure that pharmaceutical marketing practices comply with the highest ethical standards. The Code was first adopted in 2002 to govern the pharmaceutical industry's relationships with physicians and other healthcare professionals.

Hajime Shimizu, Chairman & CEO, Eisai Corporation of North America and Eisai Inc., and Board Director, PhRMA, stated, "The newly revised PhRMA Code is consistent with Eisai's established Charter of Business Conduct, which is founded on our human health care (hhc) mission to give first thought to patients and their families and to increasing the benefits that health care provides. Eisai strives to uphold the highest ethical and professional standards relevant to interactions with healthcare professionals."

The newly revised Code serves to reaffirm that interactions between company representatives and healthcare professionals remain focused on informing healthcare professionals about products, providing scientific and educational information and supporting medical research and education.

For complete information on PhRMA's Code on Interactions with Healthcare Professionals, please refer to the PhRMA web site at: http://www.phrma.org .

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with fiscal year 2007 (year ended March 31, 2008) sales of approximately $3 billion, including the results of the acquisition of MGI PHARMA, Inc.

Eisai Inc. employs approximately 1,500 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit http://www.eisai.com .


'/>"/>
SOURCE Eisai Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eisai Inc. and the Alzheimers Association Introduce the C.A.R.E. Pharmacy Award and Call for Nominations
2. Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
3. AMERIGROUP Renews Contract with Tennessee
4. WHO Report Says 9.7 Million at Risk of Death from AIDS Today; AHF Renews Call for US Congress to Commit to Scale up Treatment to Seven Million Lives
5. Blue Cross Blue Shield of Arizona Renews EDS Information Technology Services Contract
6. Hall of Fame Shortstop Cal Ripken, Jr. Renews Commitment to Lung Cancer
7. Wiley-Blackwell renews carbon neutral commitment
8. St. Marys Medical Center Renews RCM & Technology With MED3000
9. Governor Rendell Says 2008-09 Budget Renews Commitment to Vulnerable Pennsylvanians
10. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
11. ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: